2016 annual financial data
Viridian Therapeutics 2016 Operating margin
Viridian Therapeutics 2016 operating margin with verified reported values.
Direct answer
Operating margin was -374.83%.
Operating income was -12,508,000 USD and net income was -12,674,000 USD.
Operating cash flow was -7,231,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,337,000 USD
- Operating income
- -12,508,000 USD
- Net income
- -12,674,000 USD
- Operating cash flow
- -7,231,000 USD